The Behavioral Health Symposium 2026 brings together mental health professionals, clinicians, researchers, and healthcare leaders to explore the future of behavioral health care. This year’s program highlights emerging and transformative approaches, including Electroconvulsive Therapy (ECT), ketamine, MDMA, and psychedelic-assisted therapies, and the growing role of artificial intelligence in medicine and psychiatry. Through expert-led sessions and dynamic discussions, attendees will gain practical, evidence-based strategies to address the evolving challenges in mental health and substance use care, enhance collaboration across disciplines, and improve patient outcomes across diverse care settings.